Finance

Beta
Lists
JANX:NASDAQ
Janux Therapeutics Inc
$14.94
+2.47%
(+0.36) 1D
$14.94
0.00% (0.00)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JANX...
Open
$14.74
High
$15.44
Low
$14.45
Mkt. cap
911.11M
Avg. vol.
1.16M
Volume
3.70M
52-wk high
$35.34
52-wk low
$12.12
EPS
-$1.84
Beta
2.53
Shares outstanding
60.98M
No. of employees
108
Open
$14.74
High
$15.44
Low
$14.45
Mkt. cap
911.11M
Avg. vol.
1.16M
Volume
3.70M
52-wk high
$35.34
52-wk low
$12.12
EPS
-$1.84
Beta
2.53
Shares outstanding
60.98M
No. of employees
108
News stories
From sources across the web
About Janux Therapeutics Inc
CEO-
Employees108
Founded2017
Headquarters-
SectorBiotechnology
Websitejanuxrx.com
Analyst ratings
Based on 14 analysts giving stock ratings to JANX in the past 3 months
Strong buy
Buy
12
Hold
1
Sell
1
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for JANX in the last 3 months.
Highest
Current $14.94
$60.00 (+301.61%)
Average
$31.00 (+107.50%)
Lowest
$14.00 (-6.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Supawat Thongthip
Truist Financial
Buy
Initiated
$26.00
+74%
06/25/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$22.00
+47.3%
05/11/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$45.00
+201.2%
05/11/2026
Oliver McCammon
LifeSci Capital
Buy
Reiterated
$60.00
+301.6%
05/09/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$36.00
+141%
05/08/2026
Bradley Canino
Guggenheim
Buy
Reiterated
$58.00
+288.2%
05/07/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
$26.00
+74%
05/08/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
$21.00
+40.6%
05/08/2026
Boris Peaker
JonesTrading
Buy
Maintained
$28.00
+87.4%
05/08/2026
Etzer Darout
Barclays
Sell
Reiterated
$14.00
-6.3%
05/08/2026
Matt Phipps
William Blair
Buy
Reiterated
$14.00
-6.3%
05/08/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/08/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$36.00
+141%
05/08/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$38.00
+154.4%
04/28/2026
David Dai
UBS
Hold
Downgraded
$15.00
+0.4%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
$50.00
+234.7%
04/06/2026
Karina Rabayeva
Truist Financial
Buy
Reiterated
$80.00
+435.5%
03/03/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$100.00
+569.3%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
10.00M
-
3.73M
Cost of goods sold
29.18M
34.63M
31.55M
26.81M
Cost of revenue
29.18M
34.63M
31.55M
26.81M
Research and development expenses
5.49M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.45M
10.62M
10.85M
11.13M
Operating expense
15.94M
10.62M
10.85M
11.13M
Total operating expenses
45.12M
45.25M
42.40M
37.95M
Operating income
-45.12M
-35.25M
-42.40M
-34.21M
Other non operating income
-
-
-
-
EBT including unusual items
-33.86M
-24.31M
-31.95M
-24.36M
EBT excluding unusual items
-33.86M
-24.31M
-31.95M
-24.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-33.86M
-24.31M
-31.95M
-24.36M
Net profit margin
-
-243.13%
-
-652.59%
Earnings per share
-0.55
-0.39
-0.51
-0.39
Interest and investment income
11.26M
10.94M
10.46M
9.85M
Interest expense
-
-
-
-
Net interest expenses
11.26M
10.94M
10.46M
9.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.58M
-34.75M
-41.93M
-33.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of JANX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer